UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT of 1934

 

For the Month of November 2022

 

333-206723

(Commission File Number)

 

P.V NANO CELL LTD.

(Translation of registrant’s name into English)

 

8 Hamasger Street
Migdal Ha’Emek, 2310102, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): _________

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _________

 

 

 

 

 

 

EXPLANATORY NOTE

 

P.V. Nano Cell Ltd. (the “Company”) hereby furnishes the following documents:

 

  i. Notice and Proxy Statement with respect ot the Company’s annual general meeting of the shareholders to be held on December 19, 2022.
     
  ii. Proxy Card to be used with respect to the Company’s annual general meeting of the shareholdres to be held on December 19, 2022

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 29, 2022 P.V NANO CELL LTD.
   
  By: /s/ Avi Magid
    Name:  Avi Magid
    Title: Chief Executive  Officer

 

 

2